Skip to content

    Colorectal Cancer Health Center

    Font Size

    Sigmoidoscopy Cuts Risk of Colon Cancer Death: Study

    But experts note most Americans get colonoscopies instead


    In the United States, experts advise most people to begin colon cancer screening at age 50.

    The U.S. Preventive Services Task Force recommends three choices: an annual stool test; sigmoidoscopy every five years, along with stool testing every three years; or colonoscopy every 10 years.

    In practice, though, colonoscopy is by far the most common test in the United States.

    Sigmoidoscopy does have a number of advantages over colonoscopy, Holme said. The pre-exam bowel cleanse is easier to take, and the procedure itself is faster, does not require sedation and can be done by a primary care doctor or trained nurse -- whereas colonoscopies are done by gastroenterologists.

    Sigmoidoscopy is also much cheaper: In the United States, it costs about $150 to $300, versus $1,000 or more for a colonoscopy.

    But some of those advantages are not as good as they sound, according to Church. Since patients are not sedated for sigmoidoscopy, he said, it's actually more uncomfortable than colonoscopy, for example.

    What this study shows, Church said, is that sigmoidoscopy is better than no screening -- for preventing cancers on the left side of the colon.

    Among patients who were screened, there were 113 cancers per 100,000 people each year of the study. That compared with 141 per 100,000 in the unscreened group. But the difference was mostly seen in cancers in the left side of the colon.

    "For right-sided colon cancer, sigmoidoscopy is, statistically, the same as doing nothing," Church said.

    In the end, questions over how sigmoidoscopy fits into colon cancer screening could actually be moot in the near future, according to an editorial published with the study.

    New DNA stool tests, which are much more precise than standard stool tests, have the potential to reduce routine colonoscopies, writes Dr. Allan Brett, of the University of South Carolina School of Medicine in Columbia.

    "Fecal DNA tests could change the way we think about stool testing," Church said. "They're so much better than what we have now."

    Just yesterday, the U.S. Food and Drug Administration approved a DNA-based stool test that detects colon cancer with more than 90 percent accuracy. Still, experts said, the test is not intended to replace colonoscopies -- and any positive result would have to be followed up with a colonoscopy to confirm the diagnosis.

    The hope is that new and better options will encourage more people to get screened. A recent government study found that one-third of Americans eligible for colon cancer screening aren't doing it.

    1 | 2

    Today on WebMD

    Colorectal cancer cells
    The right diagnosis is the most important factor.
    man with a doctor
    Our health check will steer you in the right direction.
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    bladder cancer x-ray
    Do you know the warning signs?
    Colon vs Rectal Cancer
    New Colorectal Treatments
    can lack of sleep affect your immune system
    Cancer Facts Quiz
    Virtual Colonoscopy
    Picture of the Colon
    Vitamin D